A reduction in HSP90AB1 levels can have a preventive effect on hyperlipidemia by maintaining the stability and activity of sterol regulatory element-binding proteins (SREBP), which play a crucial role in de novo lipogenesis (DNL) [44,45]. The gene discussed is CNBP; the disease is hyperlipidemia.